What are the main practical benefits of choosing Testosterone Propionate over longer-ester testosterone options?

Testosterone propionate's primary practical benefit is dose-adjustment speed: plasma androgen levels respond to dose changes within two to four days rather than the two to three weeks required by enanthate or cypionate esters. This makes it the preferred choice for athletes who need mid-cycle flexibility, precise estrogen management, or a rapid transition into post-cycle therapy without extended washout periods.

What makes Testover P by Vermodje distinct within the Testosterone Propionate category?

Testover P is distinguished by Vermodje's two-checkpoint batch release process — an HPLC potency assay confirming concentration accuracy and an LAL endotoxin test confirming parenteral safety — before any vial is released. Combined with the 100mg/ml concentration that supports flexible whole- and half-millilitre dose construction, Testover P offers both analytical transparency and practical dosing simplicity not guaranteed across all market alternatives.

Why do experienced users specifically value the rapid estrogen control that Testosterone Propionate provides?

Because aromatase substrate — free testosterone — peaks and clears in tight alignment with each injection cycle, an aromatase inhibitor's effect is proportional and predictable. Users report that estradiol readings on bloodwork stabilise more consistently during propionate use compared to depot esters, where aromatase substrate accumulates gradually and unpredictably. This allows AI dose to be titrated to a stable maintenance level rather than chased reactively.

How does the 100mg/ml concentration of Testover P affect insulin-syringe dosing for lower weekly loads?

At 100mg/ml, each 0.1ml increment drawn into an insulin syringe equals exactly 10mg of Testosterone Propionate, enabling weekly loads as low as 70–100mg to be divided into three precise, sub-0.5ml injections. Higher-concentration formulations (150mg/ml) require smaller volumes per dose that approach the lower accuracy limit of a standard 1ml syringe, making 100mg/ml the more practical concentration for lower-load precision protocols.

What are the recommended storage conditions for a Testover P 10ml vial after it has been opened?

After first use, Testover P should be stored at room temperature (15–25°C) away from direct light and heat sources; refrigeration is unnecessary and may increase oil viscosity, complicating accurate draws. The bromobutyl rubber septum is designed to maintain sterility across multiple punctures during a standard cycle. Discard the vial if the solution becomes discoloured, cloudy, or particulate matter is visible. (2) angle_used

Verified Manufacturer

Vermodje

Testover P 100mg/ml 10ml Vial by Vermodje

Name: Testover P 100mg/ml 10ml Vial by Vermodje
Brand: Vermodje
SKU: INJ-TPRO-VER-100-023
Price: 30.00 EUR
Availability: InStock

Testover P by Vermodje delivers Testosterone Propionate at 100mg/ml in a sterile 10ml multi-dose vial — an injectable androgenic foundation engineered for athletes who prioritise rapid plasma responsiveness and injection-to-injection dose precision within structured performance cycles. The propionate ester's short enzymatic cleavage window means that androgen exposure adjusts within days of any dose change, offering a level of mid-cycle control that depot formulations cannot replicate. Every batch exits Vermodje's facility only after passing dual analytical release gates — HPLC concentration verification and LAL endotoxin clearance — confirming both potency accuracy and parenteral safety at the lot level.

€30.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Rapid plasma responsiveness enables mid-cycle dose corrections measured in days, not weeks
Predictable estrogen arc aligned to injection timing simplifies aromatase inhibitor management
100mg/ml concentration supports the widest range of dose increments using standard insulin syringes
Short ester clearance allows post-cycle therapy initiation within days of the final injection
10ml multi-dose vial covers a full cycle from a single unit with consistent septum integrity
Dual-checkpoint batch release (HPLC + LAL) provides documented concentration and endotoxin verification
Integer-friendly 0.5ml and 1.0ml draws deliver exact 50mg and 100mg increments without calculation

Phase	dosage	Note
Introductory / Assessment	100–150mg/week (EOD injections, 0.5–0.75ml per draw)	Establishes individual aromatase and androgenic response baseline; dose corrections can be applied within 3–4 days if bloodwork indicates adjustment
Performance Maintenance	200–300mg/week (EOD or 3x weekly, 0.67–1.0ml per dose)	Supports lean tissue preservation during caloric restriction or moderate surplus; estradiol should be monitored every 4–6 weeks with AI adjusted as needed
High-Output Phase	350–500mg/week (EOD, 1.0–1.25ml per injection)	Maximum practical benefit phase; injection frequency maintains stable plasma levels; haematocrit and blood pressure monitoring recommended bi-monthly
Wind-Down / Pre-PCT Taper	100mg/week reducing to 50mg over 2 weeks	Propionate's short clearance window allows HPG axis pre-conditioning before SERM-based PCT; PCT may commence 3–5 days after the final injection

Key takeaways

Choose propionate for dose adjustments that register in plasma within days.
Expect aromatase substrate — and estrogen levels — to track injection timing predictably.
Leverage the 100mg/ml concentration for integer-friendly, half-millilitre dose construction.
Confirm batch identity through Vermodje's HPLC and LAL dual-release checkpoints.
Begin SERM-based PCT within days of the last injection thanks to rapid ester clearance.

What Defines Testover P's Competitive Edge

Testover P represents a precisely formulated androgenic compound whose defining characteristic is the combination of rapid ester clearance and a confirmed 100mg/ml concentration — a pairing that grants athletes measurable control advantages unavailable with longer-ester testosterone preparations. Compared to testosterone enanthate or cypionate, propionate's abbreviated pharmacokinetic profile means that dose changes translate into altered plasma androgen levels within two to four days, not two to three weeks. This responsiveness is the foundation of every practical benefit the compound delivers.

Vermodje manufactures Testover P under GMP-aligned aseptic conditions, with each batch subjected to HPLC potency analysis confirming the declared 100mg/ml concentration within tight pharmacopoeial tolerances. The LAL (Limulus Amebocyte Lysate) endotoxin test independently validates parenteral safety at batch level — two distinct analytical gatekeeping steps that together ensure what reaches the syringe matches what is printed on the label.

Core Benefits and Distinguishing Properties

Testover P delivers several functionally distinct advantages that set it apart within the short-ester testosterone category:

Cycle control precision: Testosterone propionate enables dose escalation or reduction to register in bloodwork within a single injection interval, a documented pharmacokinetic property arising from the propanoic acid ester's rapid enzymatic cleavage by plasma and tissue esterases.
Estrogen manageability: Because aromatase substrate rises and falls in tight alignment with injection timing, estradiol management with an aromatase inhibitor (AI) is more predictable than under a long-ester protocol where aromatase substrate accumulates over extended windows.
Post-cycle transition speed: Testosterone propionate clears the system rapidly after the final injection, allowing SERM-based post-cycle therapy to commence within days — a clinically relevant advantage confirmed by the compound's established pharmacokinetic clearance data.
Volume-matched dosing: At 100mg/ml, each 1.0ml draw delivers exactly 100mg of active compound, and each 0.5ml draw delivers exactly 50mg — integer-friendly volumes that simplify dose construction without fractional arithmetic.

Concentration as a Differentiated USP

The 100mg/ml concentration positions Testover P as the most dilute — and therefore the most injection-volume-flexible — option in the short-ester testosterone segment. Higher-concentration formulations (150mg/ml) reduce oil volume per dose but compress the margin for sub-100mg dose increments. At 100mg/ml, athletes can construct weekly loads from 100mg to 400mg using straightforward whole or half-millilitre draws, preserving precise dose granularity across a wide therapeutic window.

Manufacturing Confidence and Verified Output

Every Testover P vial carries Vermodje's quality signature: GMP-compliant fill-finish operations conducted in positive-pressure laminar-flow environments, combined with batch-specific analytical documentation. The 10ml multi-dose vial format supports extended cycle use from a single unit while maintaining bromobutyl rubber septum integrity across repeated draws.

Usage

Verify the vial label and lot number against Vermodje's batch documentation; inspect the solution for clarity and confirm no particulate matter is visible before drawing.
Disinfect the rubber septum with a 70% isopropyl alcohol swab and allow it to dry fully before needle insertion to maintain sterility across multi-draw sessions.
Select injection site (gluteus medius, vastus lateralis, or deltoid for smaller volumes); rotate sites across every injection interval to distribute depot load and reduce localised tissue irritation.
Draw the calculated volume using a 21–23G draw needle, then switch to a 23–25G injection needle to minimise tissue trauma; at 100mg/ml, 0.5ml = 50mg and 1.0ml = 100mg for straightforward volume confirmation.
Administer by slow intramuscular injection over 10–15 seconds; aspirate is optional by modern clinical guidance but rotation and site hygiene remain non-negotiable.
Document each injection date, volume drawn, and site used; this log directly supports the dose-adjustment advantage that propionate's short pharmacokinetic window provides — bloodwork correlates to a clearly traceable recent dose history.

Warnings

Contraindications: Testover P is contraindicated in individuals with active or suspected androgen-sensitive malignancies (prostate or breast carcinoma), severe hepatic impairment, uncontrolled polycythaemia, and known hypersensitivity to testosterone or any excipient. Female patients of reproductive age must not use this preparation. Men with untreated obstructive sleep apnoea require specialist evaluation before initiating androgen therapy of any kind.

Side_Effects: Androgenic side effects include accelerated alopecia in genetically predisposed individuals, acne vulgaris, and increased sebaceous gland activity. Oestrogen-mediated effects — gynaecomastia and subcutaneous fluid retention — result from aromatase conversion of free testosterone and are addressed through appropriate aromatase inhibitor use. Injection-site discomfort, transient local inflammation, and post-injection pain (PIP) occur more frequently with propionate than with long-ester formulations, attributable to the propionate salt's comparatively lower pH in oil solution.

Monitoring: Serum testosterone (total and free), estradiol (sensitive assay), haematocrit, haemoglobin, LH, FSH, PSA (men over 40), lipid panel (LDL-C, HDL-C), and hepatic transaminases should be assessed at baseline and every 6–8 weeks during an active cycle. Blood pressure should be self-monitored weekly. Haematocrit exceeding 54% warrants immediate dose reduction and clinical review.

PCT: Testosterone Propionate's rapid systemic clearance after the final injection allows SERM-based post-cycle therapy — typically tamoxifen 20–40mg/day or clomiphene 50mg/day — to begin within 3–5 days of the last dose. A standard PCT duration of 4–6 weeks is appropriate following cycles of 8–12 weeks. LH and FSH recovery should be confirmed by bloodwork 4–6 weeks into PCT before discontinuing SERM support.

Frequently asked questions

What are the main practical benefits of choosing Testosterone Propionate over longer-ester testosterone options?: Testosterone propionate's primary practical benefit is dose-adjustment speed: plasma androgen levels respond to dose changes within two to four days rather than the two to three weeks required by enanthate or cypionate esters. This makes it the preferred choice for athletes who need mid-cycle flexibility, precise estrogen management, or a rapid transition into post-cycle therapy without extended washout periods.
What makes Testover P by Vermodje distinct within the Testosterone Propionate category?: Testover P is distinguished by Vermodje's two-checkpoint batch release process — an HPLC potency assay confirming concentration accuracy and an LAL endotoxin test confirming parenteral safety — before any vial is released. Combined with the 100mg/ml concentration that supports flexible whole- and half-millilitre dose construction, Testover P offers both analytical transparency and practical dosing simplicity not guaranteed across all market alternatives.
Why do experienced users specifically value the rapid estrogen control that Testosterone Propionate provides?: Because aromatase substrate — free testosterone — peaks and clears in tight alignment with each injection cycle, an aromatase inhibitor's effect is proportional and predictable. Users report that estradiol readings on bloodwork stabilise more consistently during propionate use compared to depot esters, where aromatase substrate accumulates gradually and unpredictably. This allows AI dose to be titrated to a stable maintenance level rather than chased reactively.
How does the 100mg/ml concentration of Testover P affect insulin-syringe dosing for lower weekly loads?: At 100mg/ml, each 0.1ml increment drawn into an insulin syringe equals exactly 10mg of Testosterone Propionate, enabling weekly loads as low as 70–100mg to be divided into three precise, sub-0.5ml injections. Higher-concentration formulations (150mg/ml) require smaller volumes per dose that approach the lower accuracy limit of a standard 1ml syringe, making 100mg/ml the more practical concentration for lower-load precision protocols.
What are the recommended storage conditions for a Testover P 10ml vial after it has been opened?: After first use, Testover P should be stored at room temperature (15–25°C) away from direct light and heat sources; refrigeration is unnecessary and may increase oil viscosity, complicating accurate draws. The bromobutyl rubber septum is designed to maintain sterility across multiple punctures during a standard cycle. Discard the vial if the solution becomes discoloured, cloudy, or particulate matter is visible. (2) angle_used

Manufacturer

Vermodje SRL's specialisation in specific ester variants of anabolic androgens is reflected directly in the Testover product line, which spans propionate, enanthate, and cypionate formulations — each calibrated to the ester-specific physicochemical properties that govern solubility, viscosity, and depot release kinetics. For Testover P, the propionate ester's lower molecular weight relative to enanthate or cypionate required distinct compounding parameters: oil vehicle selection, filtration-pressure thresholds, and fill-weight tolerances are all validated individually for the propionate ester rather than inherited from a generic injectable production template. This ester-specific manufacturing approach is central to Vermodje's quality philosophy — the declared 100mg/ml concentration is verified by in-process HPLC analysis at the compounding stage and again at finished-product batch release, ensuring that ester-specific formulation variables have not introduced concentration drift. Vermodje operates under GMP-aligned regulatory oversight applicable to sterile parenteral production in the Republic of Moldova, with quality frameworks cross-referenced to EU and WHO pharmaceutical manufacturing standards.

Product details

Brand	Vermodje
Active ingredient	testosterone propionate
Also known as	Testosterone Propionate, Test P, Testovis, Testover P, Vermodje Testosterone Propionate
Strength	100 mg
Form	Vial
Pack size	1 piece
Item number	INJ-TPRO-VER-100-023

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Propandrol 100mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

Established Brand

Propandrol 100mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Propandrol is a pharmaceutical-grade injectable testosterone, historically the first esterified testosterone derivative to reach clinical practice, formulated by Balkan Pharmaceuticals as Testosterone Propionate at 100 mg per millilitre in individually sealed 1 ml glass ampoules. The propionate ester — first synthesised and trialled in the 1930s — remains the benchmark short-acting testosterone form against which all later esters have been compared by endocrinologists and sports scientists alike. Batch-level sterility and potency are confirmed through validated HPLC quantification and LAL endotoxin testing; every ampoule leaving the Chișinău facility carries a traceable lot code under EU GMP Annex 1 requirements.

€36.00

Optimal Dosage

Propha-Testosterone 100mg/ml 10ml Vial by Beligas Pharmaceuticals

Propha-Testosterone by Beligas Pharmaceuticals supplies Testosterone Propionate at 100 mg/ml in a sterile 10 ml multi-dose vial — an intramuscular injectable whose short-ester architecture routes the compound directly into systemic circulation, bypassing the hepatic first-pass degradation that renders oral testosterone formats pharmacokinetically inferior. Each vial supports precise volumetric dose control across recomposition and performance phases, with plasma testosterone maintained consistently within an active physiological window throughout the cycle. Batch release is contingent on passing a dual analytical gate: reversed-phase HPLC potency confirmation and LAL endotoxin clearance, both documented per lot under GMP-compliant manufacturing conditions.

€35.00

Testopin-100 100mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Fast Acting

Testopin-100 100mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Testopin-100 is a short-ester testosterone injectable — Testosterone Propionate at 100 mg/ml — engineered for rapid onset of action, delivering measurable anabolic activity within 24–48 hours of the first injection due to Propionate's characteristically brief half-life of approximately 2–3 days. Each ampoule in this 10×1ml format provides a precisely dosed, single-use sterile unit that supports frequent administration schedules designed to maintain stable blood concentrations. Quality is assured through validated HPLC potency testing and LAL endotoxin screening at batch release; every ampoule meets pharmaceutical-grade sterility criteria before leaving the BM Pharmaceuticals facility.

€38.00

High Concentration

PropiTrex 150mg/ml 10ml Vial by Concentrex Labs

PropiTrex by Concentrex Labs delivers Testosterone Propionate at 150 mg/ml in a sterile 10 ml multi-dose vial, purpose-engineered for athletes who schedule injections around specific training days and precise clock windows. Each millilitre carries 50% more active androgen than standard 100 mg/ml propionate preparations, compressing effective dose volumes and making frequent, day-specific administration more practical. Sterility and potency are confirmed through LAL endotoxin testing and HPLC quantification at batch release; every vial exits the Concentrex Labs facility only after passing documented aseptic-processing controls.

€35.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00